Brisa S Fernandes1, Johann Steiner2, Marc L Molendijk3, Seetal Dodd4, Patricia Nardin5, Carlos-Alberto Gonçalves5, Felice Jacka4, Cristiano A Köhler6, Chandan Karmakar7, André F Carvalho6, Michael Berk8. 1. IMPACT Strategic Research Centre, Deakin University School of Medicine, and Barwon Health, Geelong, VIC, Australia; Laboratory of Calcium Binding Proteins in the Central Nervous System, Department of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. Electronic address: brisasf@gmail.com. 2. Department of Psychiatry, University of Magdeburg, Magdeburg, Germany. 3. Institute of Psychology, Department of Clinical Psychology, Leiden University Medical Center, Leiden, Netherlands; Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, Netherlands. 4. IMPACT Strategic Research Centre, Deakin University School of Medicine, and Barwon Health, Geelong, VIC, Australia. 5. Laboratory of Calcium Binding Proteins in the Central Nervous System, Department of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. 6. Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil. 7. Center for Pattern Recognition and Data Analytics, School of Information Technology, Deakin University, Geelong, VIC, Australia. 8. IMPACT Strategic Research Centre, Deakin University School of Medicine, and Barwon Health, Geelong, VIC, Australia; Florey Institute for Neuroscience and Mental Health, Department of Psychiatry and Orygen, The National Centre of Excellence in Youth Mental Health, University of Melbourne, Parkville, VIC, Australia.
Abstract
BACKGROUND: Inflammatory processes and neural-immune interactions have been implicated in the pathogenesis of psychiatric conditions, but studies in bipolar disorder are inconclusive so far. We aimed to investigate whether peripheral concentrations of C-reactive protein (CRP), an acute-phase response protein of inflammatory activity, are increased in bipolar disorder across the mood spectrum. METHODS: In this systematic review and meta-analysis, we searched MEDLINE, the Cochrane Library, Scopus, and Web of Knowledge from database inception to Aug 14, 2016, for studies that measured serum and plasma CRP concentrations in adult patients with bipolar disorder (as defined by DSM-IV-TR) and healthy controls. We extracted data from published reports. We did three between-group meta-analyses comparing CRP concentrations in patients in mania, depression, or euthymia, with those in healthy controls (cross-sectional studies), and two within-group meta-analyses comparing changes in CRP concentrations before and after treatment of an index manic or depressive episode (longitudinal studies). We used Hedges' adjusted g to calculate effect sizes and pooled results using random-effect models. We also did meta-regression analyses by mood state to investigate possible moderators of CRP concentrations. FINDINGS: We identified 27 studies representing 2161 patients with bipolar disorder and 81 932 healthy controls. Compared with healthy individuals, CRP concentrations were moderately increased in people with bipolar disorder during depression (g 0·67, 95% CI 0·23 to 1·11; p=0·003) and euthymia (0·65, 0·40 to 0·90; p<0·0001) and more substantially increased during mania (0·87, 0·58 to 1·15; p<0·0001). The extent of the increases in CRP concentrations in mania and depression was not related to symptom severity (p=0·256 for mania and p=0·626 for depression). CRP concentrations were moderately decreased after resolution of an index manic episode (-0·36, -0·66 to -0·05; p=0·022) and slightly decreased after resolution of an index depressive episode (-0·18, -0·30 to -0·07; p=0·002). INTERPRETATION: CRP concentrations are increased in bipolar disorder regardless of mood state, but are higher during mania than in depression and euthymia, suggesting an increased inflammatory burden in mania. FUNDING: None. Copyright Â
BACKGROUND: Inflammatory processes and neural-immune interactions have been implicated in the pathogenesis of psychiatric conditions, but studies in bipolar disorder are inconclusive so far. We aimed to investigate whether peripheral concentrations of C-reactive protein (CRP), an acute-phase response protein of inflammatory activity, are increased in bipolar disorder across the mood spectrum. METHODS: In this systematic review and meta-analysis, we searched MEDLINE, the Cochrane Library, Scopus, and Web of Knowledge from database inception to Aug 14, 2016, for studies that measured serum and plasma CRP concentrations in adult patients with bipolar disorder (as defined by DSM-IV-TR) and healthy controls. We extracted data from published reports. We did three between-group meta-analyses comparing CRP concentrations in patients in mania, depression, or euthymia, with those in healthy controls (cross-sectional studies), and two within-group meta-analyses comparing changes in CRP concentrations before and after treatment of an index manic or depressive episode (longitudinal studies). We used Hedges' adjusted g to calculate effect sizes and pooled results using random-effect models. We also did meta-regression analyses by mood state to investigate possible moderators of CRP concentrations. FINDINGS: We identified 27 studies representing 2161 patients with bipolar disorder and 81 932 healthy controls. Compared with healthy individuals, CRP concentrations were moderately increased in people with bipolar disorder during depression (g 0·67, 95% CI 0·23 to 1·11; p=0·003) and euthymia (0·65, 0·40 to 0·90; p<0·0001) and more substantially increased during mania (0·87, 0·58 to 1·15; p<0·0001). The extent of the increases in CRP concentrations in mania and depression was not related to symptom severity (p=0·256 for mania and p=0·626 for depression). CRP concentrations were moderately decreased after resolution of an index manic episode (-0·36, -0·66 to -0·05; p=0·022) and slightly decreased after resolution of an index depressive episode (-0·18, -0·30 to -0·07; p=0·002). INTERPRETATION:CRP concentrations are increased in bipolar disorder regardless of mood state, but are higher during mania than in depression and euthymia, suggesting an increased inflammatory burden in mania. FUNDING: None. Copyright Â
Authors: Brian Tong; Oluchi Abosi; Samantha Schmitz; Janie Myers; Gary L Pierce; Jess G Fiedorowicz Journal: Gen Hosp Psychiatry Date: 2017-12-19 Impact factor: 3.238
Authors: Mark A Frye; Brandon J Coombes; Susan L McElroy; Lori Jones-Brando; David J Bond; Marin Veldic; Francisco Romo-Nava; William V Bobo; Balwinder Singh; Colin Colby; Michelle K Skime; Joanna M Biernacka; Robert Yolken Journal: JAMA Psychiatry Date: 2019-12-01 Impact factor: 21.596
Authors: Paulo Lizano; Olivia Lutz; George Ling; Adam M Lee; Seenae Eum; Jeffrey R Bishop; Sinead Kelly; Ofer Pasternak; Brett Clementz; Godfrey Pearlson; John A Sweeney; Elliot Gershon; Carol Tamminga; Matcheri Keshavan Journal: Am J Psychiatry Date: 2019-06-05 Impact factor: 18.112
Authors: Nils Opel; Micah Cearns; Scott Clark; Catherine Toben; Dominik Grotegerd; Walter Heindel; Harald Kugel; Anja Teuber; Heike Minnerup; Klaus Berger; Udo Dannlowski; Bernhard T. Baune Journal: J Psychiatry Neurosci Date: 2019-11-01 Impact factor: 6.186
Authors: Carolina Muniz Carvalho; Frank R Wendt; Adam X Maihofer; Dan J Stein; Murray B Stein; Jennifer A Sumner; Sian M J Hemmings; Caroline M Nievergelt; Karestan C Koenen; Joel Gelernter; Sintia I Belangero; Renato Polimanti Journal: Neuropsychopharmacology Date: 2020-03-16 Impact factor: 7.853